1. Home
  2. CGBD vs QURE Comparison

CGBD vs QURE Comparison

Compare CGBD & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGBD
  • QURE
  • Stock Information
  • Founded
  • CGBD 2012
  • QURE 1998
  • Country
  • CGBD United States
  • QURE Netherlands
  • Employees
  • CGBD N/A
  • QURE N/A
  • Industry
  • CGBD Finance: Consumer Services
  • QURE Biotechnology: Pharmaceutical Preparations
  • Sector
  • CGBD Finance
  • QURE Health Care
  • Exchange
  • CGBD Nasdaq
  • QURE Nasdaq
  • Market Cap
  • CGBD 881.7M
  • QURE 750.6M
  • IPO Year
  • CGBD 2017
  • QURE 2007
  • Fundamental
  • Price
  • CGBD $18.00
  • QURE $16.98
  • Analyst Decision
  • CGBD Hold
  • QURE Strong Buy
  • Analyst Count
  • CGBD 4
  • QURE 8
  • Target Price
  • CGBD $16.25
  • QURE $32.43
  • AVG Volume (30 Days)
  • CGBD 228.5K
  • QURE 4.7M
  • Earning Date
  • CGBD 11-05-2024
  • QURE 11-05-2024
  • Dividend Yield
  • CGBD 2.67%
  • QURE N/A
  • EPS Growth
  • CGBD 29.39
  • QURE N/A
  • EPS
  • CGBD 1.72
  • QURE N/A
  • Revenue
  • CGBD $238,921,000.00
  • QURE $28,587,000.00
  • Revenue This Year
  • CGBD N/A
  • QURE $150.65
  • Revenue Next Year
  • CGBD $4.63
  • QURE N/A
  • P/E Ratio
  • CGBD $10.44
  • QURE N/A
  • Revenue Growth
  • CGBD 1.68
  • QURE N/A
  • 52 Week Low
  • CGBD $14.76
  • QURE $3.73
  • 52 Week High
  • CGBD $18.74
  • QURE $17.71
  • Technical
  • Relative Strength Index (RSI)
  • CGBD 65.73
  • QURE 75.89
  • Support Level
  • CGBD $17.61
  • QURE $14.68
  • Resistance Level
  • CGBD $18.19
  • QURE $17.71
  • Average True Range (ATR)
  • CGBD 0.32
  • QURE 1.58
  • MACD
  • CGBD 0.04
  • QURE 0.64
  • Stochastic Oscillator
  • CGBD 72.03
  • QURE 93.71

About CGBD Carlyle Secured Lending Inc.

Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Share on Social Networks: